About Latisse®

Latisse is an FDA-approved drug (bimatoprost ophthalmic solution, 0.03%) prescribed to lengthen, thicken and darken eyelashes. It has the same main ingredient as a glaucoma drug called Lumigan. Some people using Lumigan for glaucoma were surprised to find that they developed fuller, darker eyelashes.

Instead of simply creating the illusion of longer eyelashes, Latisse actually helps grow longer lashes. According to FDA data, 79% of people who use Latisse for 20+ weeks notice a significant increase in their eyelash prominence.

How To Use Latisse (5ml):

Apply to the eyelashes an average of 3x per week or roughly every other day.
The 5 ml bottle has 140 applicator brushes and is designed to last for approximately two months.

Prescription Process For Latisse:

* Valid prescription required.

Step 1. Answer A Few Questions
Please respond to the questionnaire below so that one of our MDs can evaluate you before issuing the prescription. This is a necessary, 5-minute step for us to complete your order for this prescription product.

Step 2. Place & Pay For Your Order
Go ahead and pay for your prescription order. L&P Aesthetics Skincare will not process your order or authorize your credit card until we obtain a valid prescription from Drs. Lieberman or Parikh. It is important that you leave your correct contact information so that we may follow-up with you if necessary.

Step 3. Your Medication Is Shipped
Once approved, your prescription  product will be on its way! If we cannot issue the prescription, L&P staff will follow-up with you and ensure your credit card is not charged for the product.

L&P Skincare - Prescription Order Latisse - Online Evaluation
Latisse® is an FDA approved treatment for patients with inadequate or not enough eyelashes, also referred to as hypotrichosis. The active ingredient in Latisse®, bimatoprost increases eyelash growth, including length, thickness and darkness. Eyelashes are expected to return to their previous appearance over several weeks/months after one has stopped using Latisse®. Contacts should be removed prior to applying Latisse®. Soft contact lenses can absorb the solution and should not be reinserted for at least 20 minutes after application. Being fully informed about your condition and treatment will help you make the decision whether or not to use Latisse®. This disclosure is not meant to alarm you; it is simply an effort to inform you so that you may give or withhold your consent of this treatment. Patients allergic to bimatoprost or any other ingredient in Latisse® should not use this product. Patients with recent or unexplained changes in vision should not use Latisse®. Patients with active intraocular inflammation (uveitis) should consult with their doctor before starting Latisse®. Patients with aphakia, pseudophakia patients with a torn posterior lens capsule or those with known risk factors for macular edema should use Latisse® with caution. Patients using prostaglandin analogs, including Lumigan®, for intraocular pressure reduction should consult with their doctor before starting Latisse®. Patient is 18 or older and has requested Latisse® in order to increase eyelash growth. Possible side effects of Latisse® include but are not limited to: • Itching sensation in the eyes • Increased blood in the eye • Hyperpigmentation of the skin • Irritation or redness around the eye • Dry eyes • Discoloration of the iris • Allergic reaction to an ingredient in Latisse® Infections can occur and most cases are easily treatable, however permanent scarring can occur in the area. Iris and lid pigmentation have occurred from bimatoprost use. Darkening of the eyelid can be reversible however increased brown pigmentation in the iris is most often permanent. I hereby authorize the following treatment: Latisse®. I have been informed of the risks/side effects of Latisse®. I agree to follow the provided instructions for using Latisse®. I understand lash growth will not continue after stopping Latisse®.